Arizona Clinical Trials in Tucson Announces a Novel Clinical Trial Opportunity

Join the Fight Against Seasonal Influenza.

Arizona Clinical Trials is excited to have been selected as a site for the international cutting-edge clinical trials by Moderna to establish the efficacy of a novel flu vaccine. This trial brings cutting edge science to Tucson and new clinical therapeutic options to Tucson residents.

“Be a Flu Fighter – Arm yourself against the flu—join the team, stay strong!”

Seasonal influenza A and B virus strains are a severe global public health challenge, with an estimated 3 to 5 million cases of severe illness and up to 650,000 deaths each year. The effectiveness of currently licensed seasonal influenza vaccines often falls below 60%, particularly in years when circulating virus strains do not match the vaccine antigens. This issue is especially critical for adults aged 50 and older.

We are looking for participants!

“Be a Flu Fighter – Arm yourself against the flu—join the team, stay strong!”

Requirements:

• Persons age 50 years and older.
• Not pregnant of breast feeding.

Enroll today and be a part of the future of flu prevention!

 Qualified participants may receive compensation up to $800 for trial-related time and travel.

Arizona Clinical Trials has been selected as one of a limited number of sites worldwide as a clinical trial site for this novel influenza vaccine based on mRNA technology manufactured by Moderna. This new approach could provide significant benefits over current vaccines, including quicker responses to strain changes, avoidance of mutations during production, and stronger immune responses, potentially offering better protection for older adults.

For more information or to register call  520.999.2846 or reach us at WWW.AZCLINICALTRIALS.COM